Companies to reshuffle OTC business division

Published: 2012-01-02 06:57:00

Updated: 2012-01-02 06:57:00

Some pharmaceutical companies, including Johnson&Johnson Korea, are moving toward the reshuffle of their OTC (over-the-counter) business divisions in order to ease public access to restriction-free OTC drugs at supermarkets and convenient drugs.

“Johnson&Johnson wants OTC drugs, such as Tyleno...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK